Less pain with Biatain-Ibu: Initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers

International Wound Journal

Volumn 4, Issue SUPPL.1, 2007, Pages 24-34

  Gottrup, Finn ^a,b   Jørgensen, Bo ^b   Karlsmark, Tonny ^b   Sibbald, R Gary ^c   Rimdeika, Rytis ^d   Harding, Keith ^e   Price, Patricia ^e   Venning, Vanessa ^f   Vowden, Peter ^g   Jünger, Michael ^h   Wortmann, Stephan ⁱ   Sulcaite, Rita ^d   Vilkevicius, Gintaris ^j   Ahokas, Terttu Liisa ^k   Ettler, Karel ^l   Arenbergerova, Monika ^l  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF TORONTO   (Canada)

^d KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f CHURCHILL HOSPITAL   (United Kingdom)

^g BRADFORD ROYAL INFIRMARY   (United Kingdom)

^h UNIVERSITY OF GREIFSWALD   (Germany)

ⁱ Gesundheitszentrum ^*  (Germany)

^j VILNIUS UNIVERSITY   (Lithuania)

^k HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^l CHARLES UNIVERSITY   (Czech Republic)

more..

Author keywords

Fast wound healing; Topical treatment; Wound pain intensity reduction; Wound pain relief

Indexed keywords

IBUPROFEN;

AGED; ARTICLE; BLISTER; CHRONIC WOUND; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECZEMA; FEMALE; FOAM DRESSING; HUMAN; INFECTION; LEG PAIN; LEG ULCER; LOW DRUG DOSE; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEX DIFFERENCE; SKIN ALLERGY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER HEALING; URTICARIA; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; BANDAGES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; VARICOSE ULCER; WOUND HEALING;

EID: 34047220617     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2007.00312.x     Document Type: Article

References (39)

1. Cooper SM, Hofman D, Burge SM. Leg ulcers and pain: a review. Int J Low Extrem Wounds 2003;2:189-97.
2. Hofman D, Ryan TJ, Arnold F, Cherry GW, Lindholm C, Bjellerup M, Glynn C. Pain in venous leg ulcers. J Wound Care 1997;6:222-4.
3. Phillips TJ, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994;31:49-53.
4. Briggs M, Nelson EA. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2005 (1): 23.
5. Flanagan M, Vogensen H, Haase L. Case series investigating the experience of pain in patients with chronic venous leg ulcers treated with a foam dressing releasing ibuprofen. World Wide Wounds 2006. [WWW document]. URL http://www.worldwidewounds.com/2006/april/Flanagan/Ibuprofen-Foam-Dressing.html [accessed on 2 March 2007]
6. Briggs M, Closs SJ. Patients' perceptions of the impact of treatments and products on their experience of leg ulcer pain. J Wound Care 2006;15:333-7.
7. Bosley BN, Wiener DK, Rudy TE, Granieri E. Is chronic nonmalignant pain associated with decreased appetite in older adults? Preliminary evidence. J Am Geriatr Soc 2004;52:247-51.
8. Hyde C, Ward B, Horsfall J, Winder G. Older women's experience of living with chronic leg ulceration. Int J Nurs Pract 1999;5:189-98.
9. Noonan L, Burge SM. Venous leg ulcers: is pain a problem? Phlebology 1998;13:14-19.
10. Bernstein SL, Bijur PE, Gallagher EJ. Relationship between intensity and relief in patients with acute severe pain. Am J Emerg Med 2006;24:162-6.
11. Angst MS, Brose WG, Dyck JB. The relationship between the visual analog pain intensity and pain relief scale changes during analgesic drug studies in chronic pain patients. Anesthesiology 1999;91:34-41.
12. Anonymous. ISO 14155-1: Clinical investigation of medical devices for human subjects - Part 1: General requirements. 2003.
13. Anonymous. ISO 14155-2: Clinical investigation of medical devices for human subjects - Part 2: Clinical investigation plans. 2003.
14. Steffansen B, Herping SPK. Novel wound models for characterizing the effects of exudates levels on the controlled release of ibuprofen from foam dressings. In: Gottrup F, Bale S, Franks P, Hofman D, Francu M, Price P, Romanelli M, Rybak Z, editors. European Wound Management Association Conference; 2006 May 17-20; Prague. Frederiksberg: Congress Consulting.
15. Thomson MICROMEDEX. DrugPoints® Ibuprofen. MICROMEDEX(R) Healthcare Series. 2006, 128. Thomson Micromedex, 6200 South Syracuse Way, Suite 300, Greenwood Village, Colorado.
16. Jørgensen B, Friis GJ, Gottrup F. Pain and quality of life for patients with venous leg ulcers: proof of concept of the efficacy of Biatain-Ibu, a new pain reducing wound dressing. Wound Repair Regen 2006;14:233-9.
17. Habicht A, Lophaven SN, Aagaard EB, Agerslev RH. Statistical analysis plan, DK071WO. Humlebaek, Denmark: Coloplast A/S, 2006.
18. Gilman T. Wound outcomes: the utility of surface measures. Int J Low Extrem Wounds 2004;3:125-32.
19. Sibbald RG, Coutts P, Fierheller M. Improved persistent wound pain with a novel sustained release ibuprofen foam dressing. In: Symposium for Advanced Wound Care; Poster 185; May 2006; San Antonio (TX), USA.
20. Gad P, Shewale S, Drewes A, Arendt-Nielsen L. Effect of a local ibuprofen dressing on healing of experimentally induced laser wounds. In: Gottrup F, Bale S, Franks P, Hofman D, Francu M, Price P, Romanelli M, Rybak Z, editors. European Wound Management Association Conference; 2006 May 17-20; Prague. Frederiksberg: Congress Consulting.
21. Whitlam JB, Brown KF, Crooks MJ, Room GF. Transsynovial distribution of ibuprofen in arthritic patients. Clin Pharmacol Ther 1981;29:487-92.
22. Machen J, Whitefield M. Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study. Int J Clin Pract 2002;56:102-6.
23. Simon D, Backonya M, Mersky H, Solomon S, Saper J, Lippe P, Haddox D, Aronoff G, Brose W, Gallagher RM, Krames E, Marcus N, Mauskop A, North R, Payne R, Portenoy R, Rachlin E, Ready B, Rowlingson JC, Rucker K, Stanton-Hichs M, Warfield C, Wilson P. The necessity for early evaluation and treatment of the chronic pain patient. Glenview, IL: American Academy of Pain Medicine, 1997.
24. Eriksen J, Sjøgren P. Epidemiologiske forhold vedrørende langvarige/kroniske non-cancersmertetilstande i Danmark. Ugeskrift for læger 2006;168:1947-50.
25. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 2004;5:28.
26. Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract 2003;9:S9-17.
27. Farrar JT, Young JP, LaMoreau L, Wert JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
28. Moffat CJ, Franks PJ, Hollinworth H. Understanding wound pain and trauma: an international experience. In: Briggs M, Hollinworth H, Meaume S, Pediani R, Romanelli M, Agreda JS, Torra i Bou JET, Vanscheidt W, editors. EWMA position document: pain at wound dressing changes. London: Medical Education Partnership Ltd., 2003:2-7.
29. Briggs M, Ferris FD, Harding K, Hofman D, Hollinworth H, Krasner D, Lindholm C, Moffat CJ, Price P, Romanelli M, Sibbald RG, Stacey M, Téot L. Minimising pain at wound dressing-related procedures: a consensus document. WUWHS consensus statement. London: Medical Education Partnership Ltd, 2004.
30. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS. Placebo effects mediated by endogenous opioid activity on {micro}-opioid receptors. J Neurosci 2005;25:7754-62.
31. Muller-Decker K, Hirschner W, Marks F, Furstenberger G. The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin. J Invest Dermatol 2002;119:1189-95.
32. Proper SA, Fenske NA, Burnett SM, Luria LW. Compromised wound repair caused by perioperative use of ibuprofen. J Am Acad Dermatol 1988;18:1173-9.
33. Muscara MN, McKnight W, Asfaha S, Wallace JL. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br J Pharmacol 2000;129:681-6.
34. Dvivedi S, Tiwari SM, Sharma A. Effect of ibuprofen and diclofenac sodium on experimental would healing. Indian J Expt Biol 1997;35:1243-5.
35. Radi ZA, Kahn NK. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 2005;54:358-66.
36. Abd-El-Aleem SA, Ferguson MW, Appleton I, Bhowmick A, McCollum CN, Ireland GW. Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J Pathol 2001;195:616-23.
37. Andersen KE, Franken CPM, Gad P, Larsen AM, Larsen JR, van Neer PAFA, Vuerstaek J, Wuite J, Neumann HAM. A randomized, controlled study to compare effectiveness of two foam dressings in the management of lower leg ulcers. Ostomy/Wound Manage 2002;48:31-41.
38. Nelzen O, Bergquist D, Lindhagen A. Venous and non venous leg ulcers: clinical history and appearance in a population study. Br J Surg 1994;81:182-7.
39. Ricci E, Romanelli M. An open, comparative, randomised international real life study on the clinical performance and cost-effectiveness of Biatain-Ibu versus local best practice in the treatment of painful exuding wounds. Napoli, Italy: Associazione Italiana Ulcere Cutanee (AIUC), 2006.